Agricultural biotechnology, also known as agritech, is a branch of agricultural science that involves the modification of living organisms such as plants, animals, and microorganisms using scientific tools and techniques such as genetic engineering, molecular markers, molecular diagnostics, vaccines, and tissue culture. Crop biotechnology is an area of agricultural biotechnology that has seen a lot of advancement recently. The agricultural biotechnology sector (Ag Biotech) and therapeutic biotechnology have a scientific underpinning, as well as similar characteristics such as a long time to market for developing goods. Agricultural biotechnology has the potential to improve global food security by increasing agricultural productivity and production. There is rising concern about genetically modified crops and their consequences on the food chain.
Genetics and genomics, marker-assisted selection (MAS), and transgenic (genetically modified) crops are examples of plant biotechnologies that aid in the development of novel varieties and attributes. Researchers can use these biotechnologies to find and map genes, learn about their roles, select for specific genes in genetic resources and breeding, and transfer genes for specific qualities into plants where they are needed. Plant biotechnology focusing on seed-varietal enhancement, such as GM technology and molecular-assisted breeding, has resulted in products that assist farmers in achieving higher yields in a more sustainable manner. Plant biotechnology refers to a range of approaches for adapting plants to meet specific requirements or opportunities.
Title : Molecular therapeutics for Chronic Obstructive Pulmonary Disease
Yong Xiao Wang, Albany Medical College, United States
Title : Biotech scale-up: Bioengineering imperatives in biomanufacturing
Murray Moo Young, University of Waterloo, Canada
Title : A Real BandAIdâ„¢: Incorporating Artificial Intelligence (AI) into Biomaterials and Medicine
Thomas J Webster, Hebei University of Technology, China
Title : Modulation of alternative splicing as a novel therapeutic avenue in cancer
Sebastian Oltean, University of Exeter Medical School, United Kingdom
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, resulting in eradication of implanted orthotopic tumors with no side effects
AC Matin, Stanford University School of Medicine, United States
Title : Antimicrobial electrospun fibrous scaffolds and their potential use as wound dressings
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico